Cipla 25 mg 385 Pill - yellow capsule/oblong, 22mm
Pill with imprint Cipla 25 mg 385 is Yellow, Capsule/Oblong and has been identified as Lenalidomide 25 mg. It is supplied by Cipla USA, Inc.
Lenalidomide is used in the treatment of Multiple Myeloma; Anemia; Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Lenalidomide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 25 mg 385
Lenalidomide
- Imprint
- Cipla 25 mg 385
- Strength
- 25 mg
- Color
- Yellow
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics, Other immunosuppressants
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- Genvion Corporation
- National Drug Code (NDC)
- 69097-0385
More about lenalidomide
- Check interactions
- Compare alternatives
- Reviews (28)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
